Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (58)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Panay, N
Right arrow Articles by Studd, J
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Panay, N
Right arrow Articles by Studd, J
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Reproduction Update, Vol.3, No.2 pp.159-171, 1997
© European Society of Human Reproduction and Embryology 1997; all rights reserved

Progestogen intolerance and compliance with hormone replacement therapy in menopausal women

N Panay and J Studdz

Academic Department of Obstetrics and Gynaecology, Chelsea and Westminster Hospital, 369 Fulham Road, London SW10 9NH, UK z Corresponding author

Abstract

It is vital that we maximize compliance if patients are to receive the full benefits from hormone replacement therapy (HRT). One of the main factors for reduced compliance is that of progestogen intolerance. Progestogens have a variety of effects apart from the one for which their use was intended, that of secretory transformation of the endometrium. Endometrial effects vary between individuals and between different progestogens, leading to bleeding problems. Symptoms of fluid retention are produced by the sodium-retaining effect on the renin-aldosterone system. The nor-testosterone-derived progestogens can have adverse effects on skin, lipids, vasculature and insulin resistance. Negative mood effects are produced by most progestogens due to the effect on neurotransmitters via central nervous system progesterone receptors. Manipulation of the dosage and duration of progestogen, continuous administration of a low dose of progestogen and a reduction in the number of progestogenic episodes can be used to improve compliance. The progestogen and progesterone releasing coils and vaginal progesterone gel minimize systemic side effects and bleeding. Adverse effects can also be avoided by making use of the progesterone receptor-specific progestogens such as the pregnanes (e.g. cyproterone), nor-pregnanes (e.g. nomegestrol) and progesterone itself. Hysterectomy remains an option for the severely progestogen-intolerant woman. In the future, progestogen intolerance may not be an issue if selective oestrogen receptor modulators provide a complete alternative to HRT.

Keywords: compliance/HRT/progesterone/progestogen/progestogen intolerance


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Menopause IntHome page
B. Benster, A. Carey, F. Wadsworth, A. Vashisht, C. Domoney, and J. Studd
A double-blind placebo-controlled study to evaluate the effect of progestelle progesterone cream on postmenopausal women
Menopause Int, June 1, 2009; 15(2): 63 - 69.
[Abstract] [Full Text] [PDF]

Home page
 Menopause IntHome page
R. E Nappi, G. Sances, S. Detaddei, A. Ornati, L. Chiovato, and F. Polatti
Hormonal management of migraine at menopause
Menopause Int, June 1, 2009; 15(2): 82 - 86.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
I. Bjorn, I. Sundstrom-Poromaa, M. Bixo, S. Nyberg, G. Backstrom, and T. Backstrom
Increase of Estrogen Dose Deteriorates Mood during Progestin Phase in Sequential Hormonal Therapy
J. Clin. Endocrinol. Metab., May 1, 2003; 88(5): 2026 - 2030.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
W. Cheng, O. D. Lau, and N. A. Abumrad
Two Antiatherogenic Effects of Progesterone on Human Macrophages; Inhibition of Cholesteryl Ester Synthesis and Block of Its Enhancement by Glucocorticoids
J. Clin. Endocrinol. Metab., January 1, 1999; 84(1): 265 - 271.
[Abstract] [Full Text]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.